基本信息
中文名稱:烏非拉唑
中文別名:5-甲氧基-2-(4-甲氧基-3,5-二甲基-2-吡啶基)甲基硫代-1H-苯並咪唑
英文名稱:Ufiprazole
英文別名:H 168/22; 5-METHOXY-2-(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL THIO-1H-BENZIMIDAZOLE; 5-METHOXY-2-(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYLMERCAPTOBENZIMIDAZOLE 5-METHOXY-2-[[(3,5-DIMETHYL-4-METHOXY PYRIDINYL)-METHYL]THIO]-1H-BENZIMIDAZOLE; 2-[(4-METHOXYETHOXY-3,5-DIMETHYL-2-PYRIDINYL)-METHYLTHIO]-5-METHOXYBENZIMIDAZOLE; 2-{[(3,5-dimethyl-4-methoxy-2-pyridinyl)-methyl]-thio}-5-methoxy-1h-benzimidazole; OMEPRAZOLE SULPHIDE; 5-METHOXY-2-(4-METHOXYL-3,5-DIMETHYL-PYRIDINE-2-YLMETHYLSULFENYL)- 1H- BENZIMIDA; Omeprazolesulfide; 5-METHOXY-2-(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYLTHIO-1H-BENZIMIDAZOLE(UFIPRAZOLE); 5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridinyl) methylmercapto benzimidazole; 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole
CAS:73590-85-9
分子式:C17H19N3O2S
分子量:329.4167
相對密度:1.28g/cm3
作用類別 ：
大作用類別：抗消化性潰瘍藥，其它
機理類別：H+ K+ 轉運ATP酶抑制劑
適應症：抗潰瘍
研製公司：英國阿斯利康AstraZeneca
首期專利：1981-08-13
優先權國家：瑞典
專 利 號：EP 74341
到期年代：專利已過期
現研發階段：終止
創新狀態：終止
